ATRION (ATRI) Stock Rating Lowered by BidaskClub

ATRION (NASDAQ:ATRI) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research note issued on Saturday.

Shares of ATRI stock opened at $602.00 on Friday. The firm has a market capitalization of $1,122.17, a P/E ratio of 32.78 and a beta of 0.67. ATRION has a twelve month low of $460.15 and a twelve month high of $694.00.

How to Become a New Pot Stock Millionaire

ATRION (NASDAQ:ATRI) last issued its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $4.66 earnings per share for the quarter. The company had revenue of $34.02 million for the quarter. ATRION had a return on equity of 19.53% and a net margin of 24.96%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Citadel Advisors LLC purchased a new stake in shares of ATRION in the fourth quarter worth $269,000. Stone Ridge Asset Management LLC purchased a new stake in shares of ATRION in the fourth quarter worth $271,000. Teacher Retirement System of Texas purchased a new stake in shares of ATRION in the fourth quarter worth $323,000. Bank of Montreal Can grew its stake in shares of ATRION by 25.7% in the fourth quarter. Bank of Montreal Can now owns 597 shares of the medical instruments supplier’s stock worth $376,000 after acquiring an additional 122 shares during the last quarter. Finally, MetLife Investment Advisors LLC purchased a new stake in shares of ATRION in the fourth quarter worth $390,000. 59.05% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another site, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/04/07/atrion-atri-stock-rating-lowered-by-bidaskclub.html.

ATRION Company Profile

Atrion Corp. engages in the manufacture and development of products for medical applications. It involves in the marketing of components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. It specializes in the fluid delivery, as well as ophthalmic and cardiovascular devices.

Receive News & Ratings for ATRION Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ATRION and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply